{"log_id": 5672186816400883277, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.00427, "average": 0.98766, "min": 0.575142}, "location": {"width": 825, "top": 156, "height": 36, "left": 220}, "words": "压,其确切作用机制尚不清楚,但可能通过抑制由内源性β一肾上腺素刺激而活跃的cAMP"}, {"probability": {"variance": 0.000311, "average": 0.995057, "min": 0.918429}, "location": {"width": 825, "top": 203, "height": 36, "left": 220}, "words": "合成进而发挥作用。未发现噻吗洛尔显著影响血液一房水屏障对血浆蛋白质的渗透性。家兔"}, {"probability": {"variance": 2e-06, "average": 0.998826, "min": 0.994441}, "location": {"width": 356, "top": 252, "height": 28, "left": 218}, "words": "长期使用噻吗洛尔对眼部血循环无影响"}, {"probability": {"variance": 1e-05, "average": 0.995447, "min": 0.991008}, "location": {"width": 85, "top": 348, "height": 26, "left": 219}, "words": "毒理作用"}, {"probability": {"variance": 5e-05, "average": 0.997639, "min": 0.955847}, "location": {"width": 785, "top": 394, "height": 33, "left": 258}, "words": "对于两种活性成份单独使用的眼部和全身安全性特性已充分了解。家兔眼部使用拉坦噻"}, {"probability": {"variance": 7e-06, "average": 0.998659, "min": 0.984555}, "location": {"width": 823, "top": 440, "height": 34, "left": 218}, "words": "吗滴眼液或联合使用拉坦前列素和噻吗洛尔滴眼液,未观察到眼部和全身不良反应。各成份"}, {"probability": {"variance": 6.1e-05, "average": 0.996369, "min": 0.956948}, "location": {"width": 827, "top": 485, "height": 36, "left": 215}, "words": "的安全药理学、遗传毒性和致癌性试验已揭示对人类无特别毒性。拉坦前列素对家兔角膜损"}, {"probability": {"variance": 5e-06, "average": 0.998657, "min": 0.989846}, "location": {"width": 795, "top": 532, "height": 34, "left": 213}, "words": "伤愈合无影响,而使用噻吗洛尔超过每天一次则会抑制家兔和猴子的角膜伤口愈合过程"}, {"probability": {"variance": 1e-06, "average": 0.999213, "min": 0.995059}, "location": {"width": 785, "top": 625, "height": 35, "left": 255}, "words": "未发现拉坦前列素对雄性和雌性大鼠生育力有影响,也没有发现其对大鼠和家兔产生致"}, {"probability": {"variance": 0.002489, "average": 0.987626, "min": 0.688334}, "location": {"width": 827, "top": 672, "height": 35, "left": 213}, "words": "畸作用。大鼠静脉使用剂量达250μg/kg天没有发现有胚胎毒性。但家兔静脉注射拉坦前列"}, {"probability": {"variance": 0.000126, "average": 0.99644, "min": 0.935205}, "location": {"width": 823, "top": 720, "height": 31, "left": 214}, "words": "素5μg/kg天(约为临床剂量的100倍)或高于此剂量时可引起胚胎毒性,表现为晚期吸收"}, {"probability": {"variance": 0.000195, "average": 0.99619, "min": 0.911379}, "location": {"width": 824, "top": 764, "height": 34, "left": 213}, "words": "和流产发生率增高以及胎儿体重减轻。未发现噻吗洛尔对雄性和雌性大鼠的生育能力有影"}, {"probability": {"variance": 0.000594, "average": 0.991293, "min": 0.902756}, "location": {"width": 440, "top": 813, "height": 27, "left": 213}, "words": "响,也未发现其对小鼠、大鼠和家兔有致畸作用"}, {"probability": {"variance": 0.098792, "average": 0.680335, "min": 0.366023}, "location": {"width": 97, "top": 838, "height": 60, "left": 792}, "words": "药"}, {"probability": {"variance": 1e-06, "average": 0.999186, "min": 0.996451}, "location": {"width": 136, "top": 906, "height": 26, "left": 219}, "words": "【药代动力学】"}, {"probability": {"variance": 0, "average": 0.999691, "min": 0.999324}, "location": {"width": 111, "top": 954, "height": 26, "left": 209}, "words": "拉坦前列素"}, {"probability": {"variance": 3e-06, "average": 0.998735, "min": 0.992149}, "location": {"width": 784, "top": 998, "height": 33, "left": 251}, "words": "拉坦前列素为异丙酯前体药,本身无活性,在角膜内经酯酶水解转化为拉坦前列素酸后"}, {"probability": {"variance": 0.000111, "average": 0.995379, "min": 0.94896}, "location": {"width": 825, "top": 1043, "height": 35, "left": 210}, "words": "具有生物学活性。前体药可通过角膜很好地吸收,进入房水的全部药物在透过角膜时已被水"}, {"probability": {"variance": 6.3e-05, "average": 0.997556, "min": 0.950751}, "location": {"width": 815, "top": 1090, "height": 35, "left": 208}, "words": "解。人体研究显示,拉坦前列素单独局部使用后大约2小时,其在房水中药物浓度达到峰值"}, {"probability": {"variance": 2.1e-05, "average": 0.996954, "min": 0.987668}, "location": {"width": 173, "top": 1140, "height": 25, "left": 209}, "words": "峰值浓度大约为15"}, {"probability": {"variance": 0.002151, "average": 0.986542, "min": 0.762872}, "location": {"width": 602, "top": 1140, "height": 31, "left": 433}, "words": "g/ml。猴子局部使用拉坦前列素后,药物主要分布于前房结膜和"}, {"probability": {"variance": 1.4e-05, "average": 0.995862, "min": 0.992089}, "location": {"width": 43, "top": 1188, "height": 22, "left": 207}, "words": "眼睑"}, {"probability": {"variance": 0.004565, "average": 0.980964, "min": 0.608982}, "location": {"width": 784, "top": 1278, "height": 35, "left": 249}, "words": "拉坦前列素酸的血浆清除率为0.401h/kg;分布容积小,为0.161/kg;所以血浆半衰期"}, {"probability": {"variance": 4.9e-05, "average": 0.997501, "min": 0.955128}, "location": {"width": 826, "top": 1324, "height": 35, "left": 207}, "words": "短,仅为17分钟。眼部用药后,拉坦前列素酸的全身生物利用度为45%。拉坦前列素酸的"}, {"probability": {"variance": 5e-06, "average": 0.998862, "min": 0.992262}, "location": {"width": 217, "top": 1373, "height": 27, "left": 207}, "words": "血浆蛋白结合率为87%"}, {"probability": {"variance": 0.009673, "average": 0.982561, "min": 0.384584}, "location": {"width": 790, "top": 1467, "height": 38, "left": 246}, "words": "拉坦前列素酸在眼内几乎没有代谢。代谢主要发生在肝脏。主要代谢产物为1,2二"}, {"probability": {"variance": 0.007078, "average": 0.984898, "min": 0.459706}, "location": {"width": 804, "top": 1513, "height": 36, "left": 206}, "words": "去甲基和1,2,3,4一四去甲基代谢物,在动物试验中未发现或仅发现微弱的生物活性"}, {"probability": {"variance": 1.1e-05, "average": 0.99787, "min": 0.990362}, "location": {"width": 146, "top": 1570, "height": 23, "left": 549}, "words": "第12页,共14页"}, {"probability": {"variance": 9.9e-05, "average": 0.994129, "min": 0.968089}, "location": {"width": 73, "top": 1594, "height": 19, "left": 300}, "words": "20130506"}], "language": 3}